Caption Management, LLC Astrazeneca PLC Call Options Transaction History

Caption Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $19.1 Million - $21.8 Million	249,000 New	249,000 $19.4 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $2.27 Million - $2.51 Million	35,000 Added 116.67%	65,000 $4.4 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $5.49 Million - $5.95 Million	-78,500 Reduced 72.35%	30,000 $2.15 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $2.63 Million - $2.99 Million	41,700 Added 62.43%	108,500 $7.53 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $5.24 Million - $6.8 Million	-96,600 Reduced 59.12%	66,800 $4.53 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $8.66 Million - $22.2 Million	163,400 New	163,400 $8.96 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $34.6 Million - $40.9 Million	-640,000 Reduced 72.66%	240,800 $14 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $31.1 Million - $34 Million	559,200 Added 173.88%	880,800 $52.9 Million
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $15.6 Million - $19.4 Million	321,600 New	321,600 $19.3 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $16.8 Million - $19.3 Million	-316,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $13.6 Million - $17.5 Million	316,300 New	316,300 $16.7 Million

1,349

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.